Agilon Health, Inc. (AGL) Stock Price & Analysis
Agilon Health, Inc. (AGL) fell 2.26% to USD 98 as of July 25, 2026 at 03:09 UTC, according to Nexqual real-time market data.
AGL last closed at USD 100.27; the session ranged USD 96.7–104.5 on volume of 247,474 shares. Market capitalization is $1.64B, with a 52-week range of USD 7.48–133.04 (NYQ). Source: Nexqual, July 25, 2026 at 03:09 UTC.
Key Statistics (as of July 25, 2026 at 03:09 UTC)
| Price | USD 98 |
|---|---|
| Change | ▼ 2.26% (down) |
| Previous Close | USD 100.27 |
| Open | USD 102.18 |
| Day Range | USD 96.7 – 104.5 |
| 52-Week Range | USD 7.48 – 133.04 |
| Volume | 247,474 shares |
| Market Cap | $1.64B |
| Exchange | NYQ |
Technical Analysis (AGL)
Nexqual's technical model rates AGL "NEUTRAL" based on 3 bullish and 4 bearish signals across 125 daily candles, as of July 25, 2026 at 03:09 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 40.49 (neutral) |
| vs SMA50 | Below (USD 103.65) |
| MACD | 2.92 (positive) |
Analyst Ratings (AGL)
Wall Street analysts rate AGL "Hold" based on 14 analysts, with a mean price target of USD 73.36 (range USD 22–141), per Nexqual as of July 25, 2026 at 03:09 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 14 |
| Mean Target | USD 73.36 |
| High Target | USD 141 |
| Low Target | USD 22 |
| Buy / Hold / Sell | 4 / 10 / 3 |
Earnings (AGL)
| Next Earnings Date | 2026-08-05 |
|---|---|
| EPS Estimate | USD 0.27 |
| Revenue Estimate | $1.45B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 2.32 vs est 0.93 ▲ beat |
| 2025-12-31 | USD -8.95 vs est -6.85 ▼ miss |
| 2025-09-30 | USD -6.4 vs est -3.36 ▼ miss |
| 2025-06-30 | USD -6.3 vs est -2.66 ▼ miss |
Source: Nexqual, July 25, 2026 at 03:09 UTC.
Financials & Fundamentals (AGL)
| Total Revenue | $5.82B |
|---|---|
| Revenue Growth (YoY) | -7.30% |
| Gross Margin | -2.50% |
| Operating Margin | +0.71% |
| Profit Margin | -6.09% |
| ROE | -109.59% |
| Debt / Equity | 18.41 |
| Current Ratio | 1.04 |
| Total Cash | $231.41M |
| Total Debt | $33.40M |
| Free Cash Flow | $-104.21M |
Source: Nexqual, July 25, 2026 at 03:09 UTC.
Financial Health Score (AGL)
Nexqual rates Agilon Health, Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 03:09 UTC.
| Growth | Weak — Revenue -2% YoY (annual), declining |
|---|---|
| Profitability | Critical — Gross margin -3% |
| Balance Sheet | Strong — $231M cash vs $33M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$104M, burning cash |
| Efficiency | Critical — ROE -110%, ROA -14.2% |
Ownership (AGL)
| Insider Ownership | +3.16% |
|---|---|
| Institutional Ownership | +92.87% |
| Shares Outstanding | 16.68M |
| Float | 9.80M |
| Short % of Float | +6.94% |
Source: Nexqual, July 25, 2026 at 03:09 UTC.
Leadership (AGL)
Agilon Health, Inc. is led by Timothy Patrick O'Rourke, CEO & Director, per Nexqual as of July 25, 2026 at 03:09 UTC.
| CEO & Director | Timothy Patrick O'Rourke |
|---|---|
| Executive VP & CFO | Jeffrey Alan Schwaneke (age 49) |
| Chief Technology Officer | Girish Venkatachaliah (age 51) |
| Senior Vice President of Investor Relations | Evan Smith C.F.A. |
| Markets Chief Financial Officer | Kenny Bellendir |
Major Backers & Investors (AGL)
Notable institutional backers of Agilon Health, Inc. include Clayton, Dubilier & Rice, LLC, Morgan Stanley, North Peak Capital Management, Llc, according to Nexqual as of July 25, 2026 at 03:09 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Clayton, Dubilier & Rice, LLC | 23.98% |
| Morgan Stanley | 16.97% |
| North Peak Capital Management, Llc | 9.26% |
| Goldman Sachs | 6.37% |
| AQR Capital Management, LLC | 5.84% |
| Shaw D.E. & Co., Inc. | 4.45% |
| Charles Schwab Investment Management, Inc. | 2.18% |
| Brighthouse Funds Trust I-Morgan Stanley Discovery Portfolio | 1.97% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 7.01% |
| Vanguard Group | 6.38% |
Source: Nexqual, July 25, 2026 at 03:09 UTC.
From Agilon Health, Inc.'s Latest SEC 10-K Filing (filed 2026-02-25)
Partnerships
- Our company was formed in 2016, and we established our inaugural partnership with an anchor physician group in 2017.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PRVA | Privia Health Group, Inc. | USD 25.5 | ▲ 0.51% |
| ALHC | Alignment Healthcare, Inc. | USD 19.43 | ▼ 6.45% |
| LFST | LifeStance Health Group, Inc. | USD 10.9 | ▼ 1% |
| SHC | Sotera Health Company | USD 17.35 | ▲ 0.35% |
| ALIT | Alight, Inc. | USD 18.87 | ▼ 2.38% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:09 UTC. This page is informational and not investment advice.